PerkinElmer plans to sell a less-expensive version of its newly acquired Opera technology, the Opera LX, CEO Greg Summe said during the company’s third-quarter earnings conference call last week.
 
“One of the things we need to do is take the price down on the Opera, and so we have got an R&D project that significantly takes costs and makes that a lower-priced model,” Summe said.
 
Company officials said the LX costs between 16 percent and 37 percent below the “full-blown” Opera system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.